Indutrade buys Euromed in Poland and Indutrade stock costs EUR 23.75

Published on 10/20/2026 at 13:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Indutrade buys Euromed, a SEK 230 million-revenue business. Indutrade stock costs EUR 23.75 on October 20, 2026, with third-quarter report due October 23.

Acquisition meets margin evidence

Indutrade agreed to acquire Euromed on October 19, 2026, adding SEK 230 million in annual revenue.
Q2 2026 net sales reached SEK 9.00 billion, while the EBITA margin rose to 14.70 percent.
Indutrade stock trades at EUR 23.75 at 1:34 p.m. CEST at Lang & Schwarz on October 20, 2026.

Photorealistisches Architektur-Render einer modernen Industrie- und Logistikhalle — Architektur-Rendering einer modernen Industriehalle veranschaulicht die dezentrale Unternehmensstruktur von Indutrade AB SE0001515552, Illustration mit AI erstellt.

Indutrade (SE0001515552) agreed to acquire Polish medical imaging specialist Euromed on October 19, 2026, in a deal involving a business with annual revenue of SEK 230 million, according to MarketScreener. The acquisition is expected to have a marginally positive effect on earnings per share and is subject to approval by Poland's competition authority.

Acquisition extends the niche strategy

Euromed specializes in diagnostic imaging, mainly ultrasound systems, and has 40 employees. The company is expected to join Indutrade's Life Science business area after closing, which is planned for the fourth quarter of 2026, according to MarketScreener. For investors, the important distinction is scale: Euromed's SEK 230 million in annual revenue is a portfolio addition, not a group-level transformation.

What does SEK 230 million add?

Indutrade's Q2 2026 net sales increased 11 percent to SEK 9.00 billion, while the EBITA margin reached 14.70 percent, compared with 13.70 percent in Q2 2025, according to Yahoo Finance. The acquisition therefore fits a model that combines recurring niche demand with add-on deals and margin improvement.

Three dated steps toward results

On October 2, 2026, Indutrade scheduled its January to September interim report for October 23, 2026, with a webcast at 9:30 a.m. CEST, according to Indutrade. On October 8, 2026, SB1 Markets reiterated its Buy rating with a SEK 285 target and forecast third-quarter EBITA of SEK 1.349 billion, according to MarketScreener. On October 19, 2026, Indutrade announced the Euromed acquisition with SEK 230 million in annual revenue.

Dates set the next test

The next two calendar items are October 23, 2026, for the interim report and October 23, 2026, for the management webcast, as stated by Indutrade. Those dates will put the acquisition pipeline alongside fresh third-quarter operating figures.

Stock price and portfolio scale

Indutrade stock was trading at EUR 23.75 at Lang & Schwarz on October 20, 2026, at 1:34 p.m. CEST. On Nasdaq Stockholm, the share was last at SEK 263.80 on October 20, 2026, at 1:38 p.m. CEST; the market capitalization was SEK 96.1 billion and the 52-week range was SEK 180.70 to SEK 272.20.

The further course of trading is shown by the continuously updated real-time quote of Indutrade stock.